Patricia Hurter
Senior Vice President, CMC and Preclinical Develop
Pediatric
Vertex
Austria
Biography
Dr. Hurter joined Vertex in 2004 as Head of Formulation Development, became the Vice President of Pharmaceutical Development in 2006, and is currently the Senior Vice President of CMC and Preclinical Development. The scope of her responsibilities include Pharmaceutical Development (development of chemical processes for drug substance manufacture as well as drug product formulation and process development, and associated characterization methods for activities from the discovery phase through to validation for commercial manufacturing), DMPK (preclinical drug metabolism and pharmacokinetics) and drug safety evaluation.
Research Interest
Pediatric Care, Pediatric Neurology, Pediatric Cardiology, Pediatric & Neonatal Medicine
